Hadasit Bio (Israel) Analysis

HDST Stock   42.20  2.20  5.50%   
Hadasit Bio holds a debt-to-equity ratio of 0.4. With a high degree of financial leverage come high-interest payments, which usually reduce Hadasit Bio's Earnings Per Share (EPS).
Given that Hadasit Bio's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Hadasit Bio is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Hadasit Bio to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Hadasit Bio is said to be less leveraged. If creditors hold a majority of Hadasit Bio's assets, the Company is said to be highly leveraged.
Hadasit Bio is overvalued with Real Value of 35.17 and Hype Value of 42.2. The main objective of Hadasit Bio stock analysis is to determine its intrinsic value, which is an estimate of what Hadasit Bio is worth, separate from its market price. There are two main types of Hadasit Bio's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Hadasit Bio's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Hadasit Bio's stock to identify patterns and trends that may indicate its future price movements.
The Hadasit Bio stock is traded in Israel on Tel Aviv Stock Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Sun except for officially observed holidays in Israel. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Hadasit Bio's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

Hadasit Stock Analysis Notes

About 75.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.52. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hadasit Bio last dividend was issued on the 7th of February 2019. The entity had 1:10 split on the 24th of July 2016. Hadasit Bio-Holdings, Ltd operates in the biotechnology industry in Israel. The company was founded in 2005 and is based in Jerusalem, Israel. HBL HADASIT is traded on Tel Aviv Stock Exchange in Israel. To learn more about Hadasit Bio call the company at 972 2 677 8757 or check out https://www.hbl.co.il.

Hadasit Bio Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Hadasit Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Hadasit Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Hadasit Bio is not yet fully synchronised with the market data
Hadasit Bio is way too risky over 90 days horizon
Hadasit Bio appears to be risky and price may revert if volatility continues
Hadasit Bio has high likelihood to experience some financial distress in the next 2 years
Hadasit Bio has accumulated about 18.14 M in cash with (2.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.64.
Roughly 75.0% of the company shares are held by company insiders

Hadasit Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.9 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hadasit Bio's market, we take the total number of its shares issued and multiply it by Hadasit Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Hadasit Bio Outstanding Bonds

Hadasit Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hadasit Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hadasit bonds can be classified according to their maturity, which is the date when Hadasit Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Hadasit Bio Predictive Daily Indicators

Hadasit Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Hadasit Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Hadasit Bio Debt to Cash Allocation

The company has a current ratio of 17.4, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Hadasit Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Hadasit Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hadasit Bio sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hadasit to invest in growth at high rates of return. When we think about Hadasit Bio's use of debt, we should always consider it together with cash and equity.

Hadasit Bio Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Hadasit Bio's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Hadasit Bio, which in turn will lower the firm's financial flexibility.

Hadasit Bio Corporate Bonds Issued

Most Hadasit bonds can be classified according to their maturity, which is the date when Hadasit Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

About Hadasit Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Hadasit Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hadasit shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Hadasit Bio. By using and applying Hadasit Stock analysis, traders can create a robust methodology for identifying Hadasit entry and exit points for their positions.
Hadasit Bio-Holdings, Ltd operates in the biotechnology industry in Israel. The company was founded in 2005 and is based in Jerusalem, Israel. HBL HADASIT is traded on Tel Aviv Stock Exchange in Israel.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Hadasit Bio to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Positions Ratings Now

   

Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Complementary Tools for Hadasit Stock analysis

When running Hadasit Bio's price analysis, check to measure Hadasit Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hadasit Bio is operating at the current time. Most of Hadasit Bio's value examination focuses on studying past and present price action to predict the probability of Hadasit Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hadasit Bio's price. Additionally, you may evaluate how the addition of Hadasit Bio to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges